Literature DB >> 26645660

Genuair® Usability Test: Results of a National Public Survey of the Elderly.

Francesco Blasi1, Giorgio Walter Canonica2, Stefano Centanni3, Carlo Mereu4, Roberto Bernabei5, Giuseppe Paolisso6, Raffaele Antonelli Incalzi7, Angelo Corsico8, Fabiano Di Marco3, Manlio Milanese4, Francesco Pagano5, Pierachille Santus9, Nicola Scichilone10, Massimo Sumberesi11, Fulvio Braido2, Ilaria Baiardini2.   

Abstract

Proper use of inhaler devices may be problematic in elderly patients due to age-related difficulties. A survey was administered to elderly patients to investigate the usability of the Genuair® device and patients' subjective viewpoint on the device. A representative sample of the Italian population aged ≥ 65 years was completed with a pre-defined sample of 89 patients with hand arthritis/arthrosis. Of 526 respondents, 88 were not self-sufficient. Only the replies of the 438 self-sufficient respondents were analyzed. A total of 107 participants (24%) reported having respiratory diseases, and 81 of these (76%) were users of inhaler devices. After the first test, the device was considered "practical/handy" by 90% of patients and "easy to use" by 89%. After the second test, in which patients received a demonstration of the correct inhalation maneuver, the percentage of patients scoring ≥ 7 increased to 93% for the first characteristic and was confirmed for the second, with no differences between the groups in terms of age, educational level, use of devices, and presence of arthritis/arthrosis. The mean time to explain the inhaler technique and to perform a correct inhalation was 1'38"± 1'37", and 70% of the respondents required less than 2 minutes, with no differences between the groups in terms of age, education level, use of devices, and presence of arthritis/arthrosis. In conclusion, Genuair® was well accepted and easy to use in a representative sample of the Italian population aged ≥ 65 years. These characteristics make it a valid choice in the elderly, thus enabling patients to better cope with the problems and difficulties that are common to this age group.

Entities:  

Keywords:  adherence; elderly; inhaler device; usability

Mesh:

Year:  2015        PMID: 26645660     DOI: 10.3109/15412555.2015.1067675

Source DB:  PubMed          Journal:  COPD        ISSN: 1541-2563            Impact factor:   2.409


  8 in total

Review 1.  Pharmacological Management of Elderly Patients with Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome: Room for Speculation?

Authors:  Daniela Castiglia; Salvatore Battaglia; Alida Benfante; Claudio Sorino; Nicola Scichilone
Journal:  Drugs Aging       Date:  2016-06       Impact factor: 3.923

Review 2.  New combinations in the treatment of COPD: rationale for aclidinium-formoterol.

Authors:  Cristoforo Incorvaia; Marcello Montagni; Elena Makri; Erminia Ridolo
Journal:  Ther Clin Risk Manag       Date:  2016-02-15       Impact factor: 2.423

Review 3.  Effects of aclidinium on determinants of COPD severity: symptoms and quality of life.

Authors:  Marco Contoli; Paolo Solidoro; Fabiano Di Marco; Nicola Scichilone; Angelo Corsico; Fulvio Braido; Pierachille Santus
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2016-12-05

Review 4.  Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?

Authors:  F Blasi; G W Canonica; M Miravitlles
Journal:  Respir Res       Date:  2017-01-18

Review 5.  Role of nebulized glycopyrrolate in the treatment of chronic obstructive pulmonary disease.

Authors:  Pierachille Santus; Dejan Radovanovic; Andrea Cristiano; Vincenzo Valenti; Maurizio Rizzi
Journal:  Drug Des Devel Ther       Date:  2017-11-15       Impact factor: 4.162

6.  Satisfaction, preference and error occurrence of three dry powder inhalers as assessed by a cohort naïve to inhaler operation.

Authors:  Kwun Nok Man; Zhipeng Tian; David Chi-Leung Lam; Jennifer Man Fan Wan; Kian Cheng Tan-Un
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-06-15

7.  Inhaler technique education in elderly patients with asthma or COPD: impact on disease exacerbations-a protocol for a single-blinded randomised controlled trial.

Authors:  Tiago Maricoto; Jaime Correia-de-Sousa; Luís Taborda-Barata
Journal:  BMJ Open       Date:  2019-01-28       Impact factor: 2.692

8.  A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study.

Authors:  Konstantinos Kostikas; Theodoros I Vassilakopoulos; Nikos Tzanakis; Athanasios K Konstantinidis; Epameinondas N Kosmas; Spyros Papiris; Paschalis Steiropoulos; Effrosyni D Manali; Stylianos A Michaelides; Grigorios Daskos
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2020-03-06
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.